Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
|
CN |
|
Zhejiang Dahua Technology Co Ltd
SZSE:002236
|
CN |
|
Shijiazhuang Tonhe Electronics Technologies Co Ltd
SZSE:300491
|
CN |
|
L
|
Ledesma SAAI
BCBA:LEDE
|
AR |
|
A
|
Avanza Bank Holding AB
STO:AZA
|
SE |
|
Lions Gate Entertainment Corp
NYSE:LGF.A
|
US |
|
Fintech Select Ltd
XTSX:FTEC
|
CA |
|
L
|
Luxin Venture Capital Group Co Ltd
SSE:600783
|
CN |
|
Hazama Ando Corp
TSE:1719
|
JP |
|
Adani Total Gas Ltd
NSE:ATGL
|
IN |
|
E
|
Elanco Animal Health Inc
SWB:5EA
|
US |
|
Zhongtai Futures Co Ltd
HKEX:1461
|
CN |
|
FM Mattsson AB (publ)
STO:FMM B
|
SE |
|
SWCC Showa Holdings Co Ltd
TSE:5805
|
JP |
|
T
|
Teikoku Electric Mfg. Co Ltd
TSE:6333
|
JP |
|
T
|
TH Plantations Bhd
KLSE:THPLANT
|
MY |
|
Solid State PLC
LSE:SOLI
|
UK |
|
S
|
Smithfield Foods Inc
NASDAQ:SFD
|
US |
|
H
|
Hang Xanh Motors Service JSC
VN:HAX
|
VN |
|
B
|
Bimetal Bearings Ltd
BSE:505681
|
IN |
|
San Neng Group Holdings Co Ltd
TWSE:6671
|
KY |
|
Video River Networks Inc
OTC:NIHK
|
US |
|
Agape ATP Corp
NASDAQ:ATPC
|
MY |
|
F
|
Finance of America Companies Inc
NYSE:FOA
|
US |
Multiples-Based Value
The Multiples-Based Value of one Beijing Winsunny Pharmaceutical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 22.34 CNY, Beijing Winsunny Pharmaceutical Co Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Beijing Winsunny Pharmaceutical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
B
|
Beijing Winsunny Pharmaceutical Co Ltd
SSE:601089
|
4.2B CNY | 1.2 | 9.1 | 7.7 | 7.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
847.5B USD | 13 | 41.1 | 27.7 | 29.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
576.1B USD | 6.1 | 21.5 | 14.9 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.4 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.3B USD | 4.5 | 16.1 | 10 | 12.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
218.1B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.5B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.5 | 10.5 | 7.8 | 9.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.8B USD | 2.5 | 20.2 | 7.7 | 10.3 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.6B USD | 2.5 | 17 | 7.2 | 8.8 |